Physician profile
Matthew Bracken
NPI 1275998122
$317.28
in general payments reported to CMS, 2019-2025
8 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $69.49 · 2024: $133 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $78.88 | 2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $64.68 | 2023-2024 | Zilretta, Iovera, Exparel |
| Fidia Pharma USA INC. | $53.82 | 2023-2025 | Hymovis, Triluron, Hyalgan |
| Dynasplint Systems INC. | $48.67 | 2024 | Dynasplint |
| Bioventus LLC | $26.60 | 2024 | Durolane |
| Medtronic, INC. | $17.52 | 2025 | Inceptiv |
| Tactile Systems Technology INC | $13.69 | 2023 | Entre Plus, Flexitouch Plus |
| Ossur Americas, INC. | $13.42 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bracken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.